EVENTIDE ASSET MANAGEMENT, LLC – Neurocrine Biosciences, Inc. Transaction History
EVENTIDE ASSET MANAGEMENT, LLC portfolio value:
$24.95M
portfolio value
EVENTIDE ASSET MANAGEMENT, LLC quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 2.05M | $106.21 | 235K | |
| Q2 2022 | share | 0.00% | 0 shares | 877K | $97.48 | 235K | |
| Q1 2022 | share | 0.00% | 0 shares | 2.01M | $93.75 | 235K | |
| Q4 2021 | share | 0.00% | 0 shares | -2.52M | $84.63 | 235K | |
| Q3 2021 | share | 0.00% | 0 shares | -331K | $95.91 | 235K | |
| Q2 2021 | share | Decrease | -50.42% | -239K shares | -23.22M | $97.32 | 235K |
| Q1 2021 | share | Increase | +34.28% | 121K shares | 12.26M | $97.25 | 474K |
| Q4 2020 | share | Decrease | -2.00% | -7.2K shares | -802K | $95.85 | 353K |
| Q3 2020 | share | Increase | +0.67% | 2.4K shares | -9.01M | $96.16 | 360.2K |
| Q2 2020 | share | Increase | +1.36% | 4.8K shares | 13.1M | $122 | 357.8K |
| Q1 2020 | share | 0.00% | 0 shares | -7.39M | $86.55 | 353K | |
| Q4 2019 | share | 0.00% | 0 shares | 6.13M | $107.49 | 353K | |
| Q3 2019 | share | 0.00% | 0 shares | 2.00M | $90.11 | 353K | |
| Q2 2019 | share | Increase | +30.74% | 83K shares | 6.01M | $84.43 | 353K |
| Q1 2019 | share | Increase | +73.08% | 114K shares | 12.64M | $88.1 | 270K |
| Q4 2018 | share | 0.00% | 0 shares | -8.04M | $71.41 | 156K | |
| Q3 2018 | share | 0.00% | 0 shares | 3.85M | $122.95 | 156K | |
| Q2 2018 | share | 0.00% | 0 shares | 2.38M | $98.24 | 156K | |
| Q1 2018 | share | 0.00% | 0 shares | 833K | $82.93 | 156K | |
| Q4 2017 | share | Increase | +24.80% | 31K shares | 4.44M | $77.59 | 156K |
| Q3 2017 | share | 0.00% | 0 shares | 1.91M | $61.28 | 125K | |
| Q2 2017 | share | 0.00% | 0 shares | 337K | $46 | 125K | |
| Q1 2017 | share | 0.00% | 0 shares | 575K | $43.3 | 125K | |
| Q4 2016 | share | 0.00% | 0 shares | -1.49M | $38.7 | 125K | |
| Q3 2016 | share | 0.00% | 0 shares | 649K | $50.64 | 125K | |
| Q2 2016 | share | 0.00% | 0 shares | 737K | $45.45 | 125K | |
| Q1 2016 | share | 0.00% | 0 shares | -2.12M | $39.55 | 125K |